MODULATION OF CA-125 RELEASE BY INFLAMMATORY CYTOKINES IN HUMAN PERITONEAL MESOTHELIAL AND OVARIAN-CANCER CELLS

Citation
Ag. Zeimet et al., MODULATION OF CA-125 RELEASE BY INFLAMMATORY CYTOKINES IN HUMAN PERITONEAL MESOTHELIAL AND OVARIAN-CANCER CELLS, Anticancer research, 17(4B), 1997, pp. 3129-3131
Citations number
9
Categorie Soggetti
Oncology
Journal title
ISSN journal
02507005
Volume
17
Issue
4B
Year of publication
1997
Pages
3129 - 3131
Database
ISI
SICI code
0250-7005(1997)17:4B<3129:MOCRBI>2.0.ZU;2-E
Abstract
In the present study the modulatory effects of inflammatory cytokines, interleukin-1 beta (IL-1 beta), tumor necrosis factor-alpha (TNF-alph a) and interferon-gamma (IFN-gamma), on CA-125 release in established ovarian cancer cell lines and in human peritoneal mesothelial cells (H PMC) both grown as monolayers, were investigated. The purity of mesoth elial cell cultures were confirmed by the positivity of the cells for vimentin and cytokeratins 8 and 18, and their negativity for markers C D34 and CD68, thus excluding contamination by endothelial cells and ma crophages. The preliminary results of CA-125 measurements in the cultu re medium clearly indicated differences in the pattern of CA-125 expre ssion and release between normal and malignant cells under the influen ce of inflammatory cytokines. Furthermore, it seems that normal mesoth elial cells play a crucial role as a source of CA-125 found in ascitic fluid or in pleural effusions and possibly even in the serum since se cretion of this tumor marker into the culture medium was found to be s ignificantly higher in HPMC than in ovarian cancer cells.